Today: 20 March 2026
Subscribe
Browse Category

NASDAQ:AAPL 17 January 2026 - 23 January 2026

Dow Jones drops 400 points as Goldman, Caterpillar slide and Intel jitters linger

Dow Jones drops 400 points as Goldman, Caterpillar slide and Intel jitters linger

The Dow Jones Industrial Average fell 411 points, or 0.8%, Friday afternoon, weighed down by losses in Goldman Sachs, Caterpillar, and Intel. Intel shares slumped after the company projected weaker-than-expected Q1 revenue and earnings, citing trouble meeting AI server chip demand. The S&P 500 and Nasdaq posted small gains, lifted by tech stocks. Silver topped $100 an ounce as investors sought safe havens.
23 January 2026
·········
Apple stock edges up, but India antitrust fight and Jan. 29 earnings loom for AAPL

Apple stock edges up, but India antitrust fight and Jan. 29 earnings loom for AAPL

Apple has asked the Delhi High Court to block India’s antitrust regulator from demanding its global financial records, with a hearing set for Jan. 27. Shares closed up 0.28% at $248.35 but slipped 0.03% after hours. Apple warned possible fines could reach $38 billion if global turnover is used. Investors await Apple’s Jan. 29 earnings for updates on iPhone demand and regulatory risks.
22 January 2026
····
Apple stock price today: AAPL edges up as China discounts and Siri chatbot plans hit the tape

Apple stock price today: AAPL edges up as China discounts and Siri chatbot plans hit the tape

Apple shares rose 0.4% to $247.65 Thursday after it announced price cuts of up to 1,000 yuan on select devices in China from Jan. 24–27. Bloomberg reported Apple plans to overhaul Siri into an AI chatbot this year. In India, Apple asked a Delhi court to block regulators from accessing its global financial records ahead of a Jan. 27 hearing. First-quarter earnings are due Jan. 29.
22 January 2026
··
Apple stock steady near $247 as Evercore turns bullish, Citi trims target before earnings

Apple stock steady near $247 as Evercore turns bullish, Citi trims target before earnings

Apple shares closed at $246.76 Wednesday after fluctuating between $244.85 and $248.70. Evercore upgraded Apple to “Tactical Outperform,” while Citi cut its price target, citing higher memory costs. Investors await Apple’s Jan. 29 earnings for updates on iPhone demand and profit margins. A federal judge dismissed parts of a privacy lawsuit against Apple but allowed some claims to be revised.
21 January 2026
··
Apple stock price edges up after tariff-driven selloff as AAPL earnings near

Apple stock price edges up after tariff-driven selloff as AAPL earnings near

Apple shares rose 0.2% to $247.15 early Wednesday, recovering after a 3.46% drop Tuesday. U.S. stocks remained volatile as markets awaited President Trump’s Davos speech and reacted to new tariffs on European goods. Analysts focused on Apple’s Jan. 29 earnings, weighing iPhone demand against rising costs. Evercore raised its outlook, while Citi trimmed its price target citing higher component prices.
21 January 2026
···
Apple stock slips early as tariff jitters weigh on tech; analysts point to iPhone demand

Apple stock slips early as tariff jitters weigh on tech; analysts point to iPhone demand

Apple shares fell 1.1% to $255.53 in early Tuesday trading as tariff concerns and higher component costs weighed on hardware stocks. Morgan Stanley downgraded the sector, while Evercore ISI and Citi cited strong iPhone 17 demand ahead of Apple’s Jan. 29 earnings. Investors focused on margin risks from rising memory prices. Dell, HP, and HPE also declined.
20 January 2026
···
Russell 2000 Hits Record as Small Caps Beat Big Tech — Why Wall Street Watches the First 10 Trading Days

Russell 2000 Hits Record as Small Caps Beat Big Tech — Why Wall Street Watches the First 10 Trading Days

The Russell 2000 hit a record close Jan. 16, outpacing the S&P 500 for 11 straight sessions and rising about 7.9% in 2026. Money has shifted out of big-tech ETFs, with the Roundhill Magnificent Seven ETF down 1.6% in January, while the Invesco Equal Weight S&P 500 ETF gained 3.9%. Basic materials lead U.S. sectors, up 9.05% this year, as tech slipped 0.40%.
20 January 2026
·······
Apple stock price: AAPL braces for Tuesday’s reopen as tariff jitters hit tech, earnings near

Apple stock price: AAPL braces for Tuesday’s reopen as tariff jitters hit tech, earnings near

Apple shares fell 1% to $255.53 at Friday’s close, trimming its market cap to about $3 trillion ahead of a holiday-shortened week. Nasdaq 100 futures dropped 1.25% after President Trump threatened new tariffs on Europe, hitting big tech stocks. U.S. markets are closed Monday for Martin Luther King Jr. Day. Apple’s quarterly results are due Jan. 29.
19 January 2026
····
Davos economist warns even a ‘good’ AI bubble can bite in 2026

Davos economist warns even a ‘good’ AI bubble can bite in 2026

Barclays economist Christian Keller warned at Davos that the AI-driven market surge may be a “good bubble,” but rising debt for data centers increases risks if it bursts. He said tariff-driven price hikes could hit U.S. core goods in 2026 as inventories fall. KPMG’s Diane Swonk also cautioned that heavy reliance on AI investments could leave the economy exposed to market corrections.
19 January 2026
··
Big Tech stocks head into short week with Nvidia China snag, Google antitrust appeal in focus

Big Tech stocks head into short week with Nvidia China snag, Google antitrust appeal in focus

Apple and Alphabet shares fell Friday, while Microsoft and Amazon posted small gains as the Magnificent Seven ended mixed. Nvidia suppliers halted H200 chip production for China after customs blocked shipments, according to reports. U.S. markets were closed Monday for Martin Luther King Jr. Day. Traders face earnings releases and a Supreme Court hearing this week.
18 January 2026
········
Apple stock price dips before holiday week: what to watch ahead of AAPL earnings

Apple stock price dips before holiday week: what to watch ahead of AAPL earnings

Apple shares fell 1.04% to $255.53 Friday, extending losses in after-hours trading. The drop came as U.S. stocks closed nearly flat before a long weekend and ahead of Apple’s Jan. 29 earnings report. Traders expect increased volatility after January options expiration and the holiday. Apple also reopened its expanded Sainte‑Catherine store in Montreal.
18 January 2026
···
Apple stock slides into earnings: why AAPL traders brace for a bumpier week

Apple stock slides into earnings: why AAPL traders brace for a bumpier week

Apple shares fell 1.1% to $255.53 on Friday, putting its market cap near $3 trillion ahead of its Jan. 29 earnings report. Wall Street closed little changed before the Martin Luther King Jr. Day holiday, with the S&P 500 and Nasdaq each slipping about 0.1%. Traders expect increased volatility after Friday’s options expiration. Investors are watching Apple’s margins and iPhone demand amid rising component costs.
17 January 2026
···
Apple stock price slips into holiday week as India antitrust warning and earnings near

Apple stock price slips into holiday week as India antitrust warning and earnings near

Apple shares fell 1% to $255.53 Friday, as India’s competition regulator warned it may proceed with an App Store antitrust case if Apple does not respond by next week. U.S. markets will close Monday for Martin Luther King Jr. Day. Antitrust moves against Google in the U.S. could affect payments to Apple for default search placement. About 72 million Apple shares traded Friday, with prices ranging from $254.93 to $258.90.
17 January 2026
···
1 … 4 5 6 7 8 … 43

Stock Market Today

  • Eton Pharmaceuticals Q4 Earnings Miss Estimates; Shares Up 12.5% in 2025
    March 19, 2026, 7:14 PM EDT. Eton Pharmaceuticals (ETON) reported Q4 earnings of $0.05 per share, falling short of the Zacks Consensus Estimate of $0.12 and marking a 58.33% negative earnings surprise. Revenue rose to $21.28 million, a 4.22% beat over expectations and a significant increase from $11.65 million a year earlier. Despite missing earnings, shares have gained 12.5% year-to-date, outperforming the S&P 500's 3.2% decline. The company maintains a Zacks Rank #3 (Hold), signaling expected market-aligned performance. Analysts highlight that future stock moves hinge on management guidance and upcoming earnings estimate revisions amid a mixed outlook in the Medical - Biomedical and Genetics industry.
Go toTop